Promising CART T cancer therapy invented at Penn linked to rare, secondary cancers, FDA says The Citizen 2 years ago The FDA says it has received 19 reports of new blood cancers in patients who got the CAR T treatment. Source: ABC News 6 Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on Reddit (Opens in new window) Reddit Share on LinkedIn (Opens in new window) LinkedIn Print (Opens in new window) Print Drugmakers recall blood pressure medicine tainted with cancer-causing chemical, FDA saysDateNovember 1, 2025In relation toRobesoniaZantac carcinogen: FDA says drug still safe to take amidst probeDateSeptember 14, 2019In relation toRobesoniaNearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP findsDateSeptember 5, 2024In relation toSimilar post
